Haemonetics Corporation Net Income 2009–2026
Haemonetics Corporation reported $97.31M of net income for fiscal 2026. That was 42.0% lower than fiscal 2025. Compared with fiscal 2021, the change was +22.4%.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2026 | $97.31M | 7.3% | -42.0% |
| FY 2025 | $167.68M | 12.3% | +42.6% |
| FY 2024 | $117.56M | 9.0% | +1.9% |
| FY 2023 | $115.40M | 9.9% | +166.1% |
| FY 2022 | $43.38M | 4.4% | -45.4% |
| FY 2021 | $79.47M | 9.1% | +3.8% |
| FY 2020 | $76.53M | 7.7% | +39.1% |
| FY 2019 | $55.02M | 5.7% | +20.7% |
| FY 2018 | $45.57M | 5.0% | +273.5% |
| FY 2017 | $-26.27M | -3.0% | +52.7% |
| FY 2016 | $-55.58M | — | -428.9% |
| FY 2015 | $16.90M | 1.9% | -51.9% |
| FY 2014 | $35.15M | 3.7% | -9.4% |
| FY 2013 | $38.80M | 4.3% | -42.0% |
| FY 2012 | $66.89M | 9.2% | -16.4% |
| FY 2011 | $79.98M | 11.8% | +37.0% |
| FY 2010 | $58.37M | 9.0% | -1.6% |
| FY 2009 | $59.30M | — | — |
Source: Haemonetics Corporation SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HAE 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Haemonetics Corporation reported $97.31M of net income for fiscal 2026. That was 42.0% lower than fiscal 2025. Compared with fiscal 2021, the change was +22.4%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Haemonetics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHaemonetics Corporation — frequently asked questions
What is Haemonetics Corporation's net income?
Haemonetics Corporation (HAE) reported net income of $97.31M for fiscal year 2026, per its SEC filings.
How has Haemonetics Corporation's net income changed over time?
Between fiscal 2009 and 2026, HAE's net income grew at roughly 3.0% per year (compound annual rate), from $59.30M to $97.31M.
Where does this data come from?
Figures are computed from Haemonetics Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.